Notably, the cytokeratin 19 (CK19)+ tumor compartment was also reduced in the transplants with HDAC-deficient CAFs (Fig. 6d), largely proportionally to the α-SMA+ fibroblast compartment (Fig. 6e), indicating lower tumor-promoting effect from HDAC-deficient CAFs. The gene discussed is KRT19; the disease is neoplasm.